Optimising basal-bolus therapy in type 2 diabetes: a randomised, controlled trial comparing bolus insulin delivery using an insulin patch vs an insulin pen

被引：0
|
作者：
Ramtoola, S. [1 ]
Aroda, V. R. [2 ]
Bailey, T. S. [3 ]
Brazg, R. L. [4 ]
Dreon, D. M. [5 ]
Frias, J. P.
Klonoff, D. C. [6 ]
Kruger, D. F.
Levy, B. L. [5 ]
Peyrot, M. [7 ]
Rosenstock, J. [8 ]
Serusclat, P. [9 ]
Weinstock, R. S. [10 ]
Zraicks, V.
Bergenstal, R. M. [11 ]
机构：
[1] East Lancashire Hosp NHS Trust, Blackburn, Lancs, England
[2] Medstar Hlth Res Inst, Hyattsville, MD USA
[3] AMCR Inst Inc, Escondido, TN USA
[4] Rainier Clin Res Ctr, Renton, WA USA
[5] Calibra Med, Wayne, NJ USA
[6] Diabet Res Inst, San Mateo, NJ USA
[7] Loyola Univ Maryland, Baltimore, MD USA
[8] Dallas Diabet Res Ctr Med City, Dallas, TX USA
[9] Grp Hosp Mutualiste Portes Sud, Venissieux, France
[10] SUNY Upstate Med Univ, Syracuse, NY USA
[11] Int Diabet Ctr, Minneapolis, MN USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
809
引用
收藏
页码：S397 / S397
页数：1
相关论文
共 50 条
  • [21] Comparison of insulin lispro protamine suspension and insulin detemir in basal-bolus therapy in patients with Type 1 diabetes
    Chacra, A. R.
    Kipnes, M.
    Ilag, L. L.
    Sarwat, S.
    Giaconia, J.
    Chan, J.
    DIABETIC MEDICINE, 2010, 27 (05) : 563 - 569
  • [22] BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA
    Bueno, Elvio
    Benitez, Aldo
    Vera Rufinelli, Jazmin
    Figueredo, Rafael
    Alsina, Shirley
    Ojeda, Aldo
    Samudio, Sandra
    Caceres, Mirta
    Arguello, Rocio
    Romero, Fabiola
    Echague, Gloria
    Pasquel, Francisco
    Umpierrez, Guillermo E.
    ENDOCRINE PRACTICE, 2015, 21 (07) : 807 - 813
  • [23] OPTIMAL REGIMENS OF THE BASAL-BOLUS INSULIN THERAPY IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
    Galkina, G. A.
    Voropay, A. A.
    Levkovich, M. A.
    Vorobiov, S. V.
    Komkova, M. V.
    Morozova, N. V.
    BYULLETEN SIBIRSKOY MEDITSINY, 2015, 14 (05): : 15 - U223
  • [24] Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
    Garber, Alan J.
    King, Allen B.
    Del Prato, Stefano
    Sreenan, Seamus
    Balci, Mustafa K.
    Munoz-Torres, Manuel
    Rosenstock, Julio
    Endahl, Lars A.
    Francisco, Ann Marie Ocampo
    Hollander, Priscilla
    LANCET, 2012, 379 (9825): : 1498 - 1507
  • [25] CLINICAL EFFECTIVENESS OF SWITCHING FROM INSULIN PEN DEVICES TO A 24-HR WEARABLE INSULIN DELIVERY DEVICE IN PATIENTS WITH TYPE 2 DIABETES PRESCRIBED BASAL-BOLUS THERAPY
    Hundal, R.
    Kowalyk, S. Kowalyk
    Cases, J.
    Al-Kardsheh, A.
    Wakim, A. P.
    Doyle, M.
    Spence, A.
    Sink, J.
    Brewer, J.
    Nikkel, C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A132 - A132
  • [26] "SURPASS(ing)" an Era of Basal-Bolus Insulin Therapy-Tirzepatide vs. Insulin Lispro TID Added-on to Poorly Controlled Basal Insulin-Treated in Type 2 Diabetes
    Rosenstock, Julio
    Frias, Juan P.
    Rodbard, Helena W.
    Tofe, Santiago
    Sears, Emmalee J.
    Huh, Ruth
    Lando, Laura Fernandez
    Patel, Hiren
    DIABETES, 2023, 72
  • [27] Efficacy and safety of insulin degludec/liraglutide (IDegLira) vs basal-bolus therapy in patients with type 2 diabetes: DUAL VII trial
    Billings, L. K.
    Doshi, A.
    Gouet, D.
    Oviedo, A.
    Rodbard, H. W.
    Tentolouris, N.
    Gron, R.
    Halladin, N.
    Jodar, E.
    DIABETOLOGIA, 2017, 60 : S366 - S366
  • [28] THE COSTS OF INTENSIFICATION FROM BASAL INSULIN TO BASAL-BOLUS IN TYPE 2 DIABETES: A SURVEY OF PHYSICIANS
    Pfeiffer, K. M.
    Basse, A.
    Brod, M.
    VALUE IN HEALTH, 2018, 21 : S74 - S74
  • [29] The Effect of Type and Daily Doses of Insulin to Treatment Success in Type 2 Diabetes Patients who are Receiving Basal-bolus Insulin Therapy
    Ozturkmen, Yuksel Asli
    Avci, Suna
    Calim, Aslihan
    Cetin, Elif Guven
    Demir, Nazan
    Mazi, Emrah Erkan
    Borlu, Fatih
    Altuntas, Yuksel
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2020, 54 (04): : 416 - 423
  • [30] Proportion and characteristics of patients with type 2 diabetes initiating basal insulin therapy with a basal-bolus regimen in China
    Zhang, Puhong
    Zhang, Heng
    Zhu, Dongshan
    Li, Xian
    Ji, Jiachao
    Zhao, Fang
    Lu, Juming
    Jia, Weiping
    Ji, Linong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
12345